Medical News

RSS

MHI team uses cryoablation to successfully treat atrial fibrillation

The electrophysiology team at the Montreal Heart Institute (MHI) used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity.

From Medtronic 11 May 2011

Response Biomedical first quarter total revenues increase 59% to $2,470,560

Response Biomedical Corporation reported financial results for the first quarter ended March 31, 2011. Total revenues for the three-month period ended March 31, 2011 increased 59% to $2,470,560 compared to $1,549,479 for the same period last year.

11 May 2011

Catasys commences enrollment for integrated substance dependence program in Nevada

Catasys, Inc. announced today that it has launched and begun enrollment for its integrated substance dependence program, called OnTrak™, in Nevada.

11 May 2011

American Medical Alert first quarter net income increases 18% to $1,046,378

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter ended March 31, 2011, the

11 May 2011

Santaris Pharma advances SPC4955 into Phase 1 trial for high cholesterol treatment

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the research and development of mRNA and microRNA targeted therapies, today announced that it has advanced a second drug from its cardiometabolic program, SPC4955 into Phase 1 clinical trials, for the treatment of high cholesterol.

11 May 2011

Winner Medical second quarter net sales increase 27% to $33.2 million

Winner Medical Group Inc., a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton products in China, today reported consolidated financial results for the second quarter ended March 31, 2011.

11 May 2011

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

11 May 2011

China Pharma first quarter revenue increases 20% to $18.1 million

China Pharma Holdings, Inc., a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011.

11 May 2011

First Edition: May 11, 2011

Reporting for Kaiser Health News, Hilary Abramson writes: "Now comes the hard part. California, which has had a long, sometimes-tortured history of trying to overhaul its health care markets, beat every other state last year when it passed a law creating a health insurance exchange - an online marketplace where millions of uninsured residents will be able to get insurance".

11 May 2011

SAFC, Oncolytics Biotech sign commercial supply agreement for REOLYSIN

Oncolytics Biotech Inc. today announced that it has entered into a commercial supply agreement with SAFC, a Division of Sigma-Aldrich Corporation, for the commercial manufacture of REOLYSIN, Oncolytics proprietary reovirus.

11 May 2011

AspirinWorks Test now available in greater Boston and surrounding area

A simple urine test that measures aspirin effect is now available in the greater Boston and surrounding area. The AspirinWorks Test is available to eastern Massachusetts and southern New Hampshire area doctors through Diagnostic Laboratory Medicine.

11 May 2011

New poll: Ontarians support more public investment in home and community support services

A new poll shows Ontarians support more public investment in home and community support services with six in ten (59%) agreeing new funding is better designated to these preventative care services rather than facilities and full-time nursing care.

11 May 2011

TSO3 first quarter revenue decreases to $136,628

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings, posted revenues of $136,628 for the first quarter of 2011 ending March 31, for the sale of supplies, accessories and service contracts for the first generation product.

11 May 2011

Two new policy briefs on California health reform law

According to two new policy briefs from the UCLA Center for Health Policy Research, the majority of state residents likely to be eligible for federally mandated health insurance coverage initiatives in California in 2014 are also those who may be least likely to excessively use costly health services: men, singles and those of working age.

11 May 2011

Baylor has now patented new polarimeter that could prove useful in pharmaceuticals

Two Baylor University chemistry professors have invented a new polarimeter, a basic scientific instrument used to measure and interpret the polarization of transverse waves, such as light waves, that could prove useful in determining the purity of pharmaceuticals. Baylor has now patented the device.

11 May 2011

Symphogen to present second-generation Sympress platform at ESACT conference

Symphogen, a private biopharmaceutical company developing superior antibody therapeutics to treat cancer, infectious and autoimmune diseases, announced today that second-generation enhancements to the company's SYMPRESS manufacturing and quality control platform will be presented in an oral presentation entitled "Recombinant antibody mixtures; optimization of cell line generation and single-batch manufacturing processes" by Dr. Søren K. Rasmussen, Principal Scientist, Symphogen at the upcoming European Society for Animal Cell Technology conference in Vienna on May 17, 2011.

11 May 2011

HBA to host panel discussion on Accountable Care Organizations

Accountable Care Organizations: Accountable? Affordable? Achievable?—A panel discussion presented by the Southern California HBA featuring a distinguished group of local healthcare industry leaders.

11 May 2011

Identigene announces availability of DNA paternity test kit in New York drug stores

Identigene today announced that the Identigene DNA Paternity Test Kit is now available in chain drug stores and independent pharmacies throughout the state of New York, expanding sales from 260 retail locations in the New York City area to more than 1,600 stores across the state.

11 May 2011

Naurex announces completion of $18 million Series A financing

Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of an $18 million Series A financing led by Adams Street Partners and Latterell Venture Partners.

11 May 2011

TSA, Psyadon Pharmaceuticals partner for ecopipam clinical trial in Tourette Syndrome

The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.

11 May 2011